Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.620
-0.120 (-2.53%)
Jul 30, 2026, 10:12 AM EDT - Market open
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Foghorn Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $11.44. The average 1-year stock price forecast is 147.62% higher than the current stock price, while the lowest is $9.00 (+94.81%) and the highest is $14 (+203.03%).
Price Target: $11.44 (+147.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $10 | Buy | Maintains | $10 | +116.45% | Jul 20, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $12 | Buy | Maintains | $12 | +159.74% | Jun 1, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $12 | Buy | Maintains | $12 | +159.74% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +181.39% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
Financial Forecast
Revenue This Year
25.84M
from 30.91M
Decreased by -16.40%
Revenue Next Year
37.42M
from 25.84M
Increased by 44.81%
EPS This Year
-1.06
from -1.21
EPS Next Year
-1.10
from -1.06
EPS and Forward PE are based on non-GAAP adjusted numbers.